Theravance Biopharma shares owned by GSA Capital Partners
Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by GSA Capital Partners
from 13F filings
Historical chart of GSA Capital Partners investment in Theravance Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Theravance Biopharma held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Theravance Biopharma by GSA Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.9M | 230k | 8.06 |
| 2024-06-30 | $1.7M | 204k | 8.48 |
| 2023-12-31 | $866k | 77k | 11.24 |
| 2023-09-30 | $2.8M | 326k | 8.63 |
| 2023-06-30 | $206k | 20k | 10.34 |
| 2023-03-31 | $1.1M | 105k | 10.85 |
| 2022-12-31 | $646k | 58k | 11.22 |
| 2022-06-30 | $1.0M | 115k | 9.06 |
| 2022-03-31 | $473k | 50k | 9.56 |
| 2020-09-30 | $206k | 14k | 14.75 |
| 2019-09-30 | $209k | 11k | 19.45 |